Development of treatment and clinical results in childhood acute myeloid leukemia in Slovenia in the period from 1991 to 2010

[1] Avcin S(2011)History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia MEMO 4 178-83

[2] Prelog T(2009)Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 Trial From the Japanese Childhood AML Cooperative Study Group J Clin Oncol 27 4007-13

[3] Kavcic M(2010)Acute myeloid leukemia Hematol Oncol Clin North Am 24 35-63

[4] Kitanovski L(2006)Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions Cancer 106 2495-502

[5] Anzic J(2004)Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience Cancer 101 1677-84

[6] Benedik Dolnicar M(2008)Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A Cancer 112 562-71

[7] Rajic V(2004)The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups Haematologica 89 1082-90

[8] Zadravec Zaletel L(2001)Clinicopathologic characteristics of leukemia in Japanese children and young adults Leukemia 15 1256-61

[9] Debeljak M(2002)Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation Blood 100 427-34

[10] Jazbec J(2005)Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment Pediatr Blood Cancer 44 1-7

[1] Avcin S(2011)History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia MEMO 4 178-83

[2] Prelog T(2009)Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 Trial From the Japanese Childhood AML Cooperative Study Group J Clin Oncol 27 4007-13

[3] Kavcic M(2010)Acute myeloid leukemia Hematol Oncol Clin North Am 24 35-63

[4] Kitanovski L(2006)Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions Cancer 106 2495-502

[5] Anzic J(2004)Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience Cancer 101 1677-84

[6] Benedik Dolnicar M(2008)Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A Cancer 112 562-71

[7] Rajic V(2004)The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups Haematologica 89 1082-90

[8] Zadravec Zaletel L(2001)Clinicopathologic characteristics of leukemia in Japanese children and young adults Leukemia 15 1256-61

[9] Debeljak M(2002)Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation Blood 100 427-34

[10] Jazbec J(2005)Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment Pediatr Blood Cancer 44 1-7